Related Experiment Video
Updated: Mar 5, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Improving public health by improving clinical trial guidelines and their application
Martin J Landray1, Jeroen J Bax2, Laurence Alliot3
1Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Randomized controlled trials (RCTs) are crucial for cardiovascular therapeutics. Current large-scale RCTs face sustainability concerns, prompting a need for meaningful change in cardiovascular clinical research conduct.
Area of Science:
- Cardiology
- Clinical Trials
- Evidence-Based Medicine
Background:
- Randomized controlled trials (RCTs) are fundamental to advancing cardiovascular therapeutics, guiding the adoption of effective treatments and avoidance of harmful interventions.
- Cardiovascular research has evolved significantly, with modern RCTs requiring large patient cohorts, multiple international sites, and substantial infrastructure.
- Concerns exist regarding the sustainability of current large-scale RCT models, potentially hindering the evaluation of new and existing cardiovascular treatments.
Purpose of the Study:
- To summarize key insights and discussions from the European Society of Cardiology Cardiovascular Roundtable meeting in October 2015 regarding the challenges in cardiovascular clinical research.
- To highlight subsequent progress made in addressing these challenges.
- To identify actionable next steps for improving the conduct of cardiovascular clinical research.
Main Methods:
- The study is based on discussions and insights from a meeting involving patients, regulators, funders, and trialists.
- Key issues concerning the current approach to cardiovascular clinical trials were considered.
- The paper synthesizes these discussions to propose future directions.
Main Results:
- The meeting identified significant concerns about the sustainability and efficiency of large, multi-center, international cardiovascular RCTs.
- Progress has been made in addressing some of the identified challenges since the 2015 meeting.
- Specific next steps for meaningful change in cardiovascular clinical research were outlined.
Conclusions:
- The current model of large-scale cardiovascular RCTs faces sustainability challenges that may impede patient care.
- Collaborative efforts involving all stakeholders are essential for implementing necessary changes in clinical trial conduct.
- Continued progress and adaptation are vital for the future of effective cardiovascular clinical research.
More Related Videos
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...